Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Cancer Research
|
January 2, 2025
MICAL2 Promotes Pancreatic Cancer Growth and Metastasis
Bharti Garg, Sohini Khan, Asimina S Courelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2020
Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics
James T Topham, Joanna M Karasinska, Michael K C Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2020
Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?
Erica S Tsang, James T Topham, Joanna M Karasinska, et al.
Biorxiv : the Preprint Server for Biology
|
October 14, 2024
nSMase2-mediated exosome secretion shapes the tumor microenvironment to immunologically support pancreatic cancer
Audrey M Hendley, Sudipta Ashe, Atsushi Urano, et al.
NPJ Precision Oncology
|
April 4, 2025
The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer
Abdul R Farooq, Amy X Zhang, Michelle Chan-Seng-Yue, et al.
Iscience
|
August 12, 2025
Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma
James T Topham, Joanna M Karasinska, Andrew Metcalfe, et al.
Immunity
|
February 9, 2022
Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity
Kebria Hezaveh, Rahul S Shinde, Andreas Klötgen, et al.
Cancer Cell
|
August 30, 2024
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
Caitlin A McIntyre, Adrien Grimont, Jiwoon Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2020
A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer
Joan M Romero, Barbara Grünwald, Gun-Ho Jang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 31, 2017
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial
Kyaw L Aung, Sandra E Fischer, Robert E Denroche, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Cancer Research
|
January 2, 2025
MICAL2 Promotes Pancreatic Cancer Growth and Metastasis
Bharti Garg, Sohini Khan, Asimina S Courelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 14, 2020
Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics
James T Topham, Joanna M Karasinska, Michael K C Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2020
Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?
Erica S Tsang, James T Topham, Joanna M Karasinska, et al.
Biorxiv : the Preprint Server for Biology
|
October 14, 2024
nSMase2-mediated exosome secretion shapes the tumor microenvironment to immunologically support pancreatic cancer
Audrey M Hendley, Sudipta Ashe, Atsushi Urano, et al.
NPJ Precision Oncology
|
April 4, 2025
The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer
Abdul R Farooq, Amy X Zhang, Michelle Chan-Seng-Yue, et al.
Iscience
|
August 12, 2025
Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma
James T Topham, Joanna M Karasinska, Andrew Metcalfe, et al.
Immunity
|
February 9, 2022
Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity
Kebria Hezaveh, Rahul S Shinde, Andreas Klötgen, et al.
Cancer Cell
|
August 30, 2024
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
Caitlin A McIntyre, Adrien Grimont, Jiwoon Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2020
A Four-Chemokine Signature Is Associated with a T-cell-Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer
Joan M Romero, Barbara Grünwald, Gun-Ho Jang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 31, 2017
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial
Kyaw L Aung, Sandra E Fischer, Robert E Denroche, et al.
Page
of 7